摘要
目的研究老年Ⅲ期结肠癌患者术后临床及病理因素对预后的影响,并进行相关因素分析,以期为临床预后评估提供参考。方法回顾性分析2008年1月至2012年12月208例接受根治性手术切除后的老年Ⅲ期结肠癌患者的临床资料,采用Kaplan-Meier法计算老年结肠癌患者总生存率,采用Log-rank检验和多因素Cox回归分析分析影响患者生存的因素。结果老年Ⅲ期结肠癌患者5年生存率为55. 5%。单因素分析显示,不同年龄、肿瘤大小、组织学类型、组织学分级、脉管癌栓侵犯、神经浸润、T分期、N分期、美国癌症联合委员会(AJCC)分期、术前癌胚抗原(CEA)水平、化疗与否患者中5年总生存率比较有统计学差异(P <0. 05,P <0. 01)。Cox多因素分析显示,年龄、脉管癌栓、T分期、N分期、AJCC分期、术前CEA水平、化疗为老年Ⅲ期结肠癌患者预后的影响因素(P <0. 05)。结论对于老年Ⅲ期结肠癌,TNM体系仍是判断预后的可靠指标,但需考虑年龄(≥70岁)、脉管癌栓、术前CEA因素对预后的影响。此外老年Ⅲ期结肠癌患者术后化疗能明显获益,应对术后辅助化疗持积极态度。
Objective To investigate the influence of postoperative clinical and pathological factors on prognosis in elderly patients with stage Ⅲ colon cancer,and survival analysis was conducted in order to provide reference for clinical prognosis evaluation. Methods The clinical and pathological data of 208 elderly patients with stage Ⅲ colon cancer after radical resection were retrospectively analyzed,and all cases were followed up. Kaplan-Meier method was used to calculate the overall survival rate of elderly patients with colon cancer. Log-rank test and multivariate COX regression analysis were used to analyze the factors of influencing patients' survival. Results The 5-year survival rate of elderly patients with stage Ⅲcolon cancer was 55. 5%. Univariate analysis showed that age,tumor size,histological type,histological grade,vascular carcinoma embolus invasion,neural infiltration,T staging,N staging,American Joint Committee on Cancer( AJCC) staging,preoperative carcinoembryonic antigen( CEA) level and chemotherapy were poor prognostic factors( P < 0. 05,P < 0. 01).Further,Cox multivariate analysis showed that age,vascular carcinoma embolus,T staging,N staging,AJCC staging,preoperative CEA level and chemotherapy were the independent prognostic factors affecting survival( P < 0. 05,P < 0. 01).Conclusions For elderly patients with stage Ⅲ colon cancer,TNM system is still a reliable indicator judging prognosis,but the affects of age( > 70 years old),vascular carcinoma embolus and preoperative CEA level on prognosis should be considered. Additionally,postoperative chemotherapy can significantly benefit in elderly patients with stage Ⅲ colon cancer,so the patients should take a positive attitude towards postoperative adjuvant chemotherapy.
引文
[1]陈功,万德森.结直肠癌防治研究最新进展[J].广东医学,2016,37(22):3323-3328.
[2]Stewart BW,Wild CP.World cancer report 2014[M].Geneva:International Agency for Research on CancerWHO Press,2014.
[3]Siegel RL,Miller KD,Fedewa SA,et al.Colorectal cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):177-193.
[4]Auclin E,Zaanan A,Vernerey D,et al.Subgroups and prognostication in stageⅢcolon cancer:future perspectives for adjuvant therapy[J].Annals of Oncology,2017,28(5):958-968.
[5]Mármol I,Sánchez-de-Diego C,Pradilla Dieste A,et al.Colorectal carcinoma:a general overview and future perspectives in colorectal cancer[J].Int J Mol Sci,2017,18(1):197.
[6]潘宏达,彭亦凡,王林,等.Ⅲ期结肠癌患者预后因素分析和术前对预后评估的探索[J].肿瘤防治研究,2013,40(11):1059-1063.
[7]Sinicrope FA,Foster NR,Yoon HH,et al.Association of obesity with DNA mismatch repair status and clinical outcome in patients with stageⅡorⅢcolon carcinoma participating in NCCTG and NSABPadjuvant chemotherapy trials[J].J Clin Oncol,2012,30(4):406-412.
[8]Sinicrope FA,Mahoney MR,Smyrk TC,et al.Prognostic impact of deficient DNA mismatch repair in patients with stageⅢcolon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy[J].J Clin Oncol,2013,31(29):3664-3672.
[9]Edge SB,Compton CC.The American joint committee on cancer:the7th edition of the AJCC cancer staging manual and the future of TNM[J].Ann Surg Oncol,2010,17(6):1471-1474.
[10]AJCC cancer staging handbook[M].7th.New York:Springer,2010:144.
[11]V9lkel V,Draeger T,Gerken M,et al.Long-term survival of patients with colon and rectum carcinomas:is there a difference between cancer centers and non-certified hospitals?[J].Gesundheitswesen,2018.[Epub ahead of print]
[12]Draeger T,V9lkel V,Gerken M,et al.Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection:a high-quality population-based analysis in a Southern German district[J].Surg Endosc,2018,32(10):4096-4104.
[13]Puccini A,Berger MD,Zhang W,et al.What we know about stageⅡandⅢcolon cancer:it's still not enough[J].Target Oncol,2017,12(3):265-275.
[14]Auclin E,Zaanan A,Vernerey D,et al.Subgroups and prognostication in stageⅢcolon cancer:future perspectives for adjuvant therapy[J].Ann Oncol,2017,28(5):958-968
[15]Obuch JC,Ahnen DJ.Colorectal cancer:genetics is changing everything[J].Gastroenterol Clin North Am,2016,45(3):459-476.
[16]Tan Y,Wu H.The significant prognostic value of circulating tumor cells in colorectal cancer:a systematic review and meta-analysis[J].Curr Probl Cancer,2018,42(1):95-106.
[17]Benson AB 3rd,Venook AP,Cederquist L,et al.Colon cancer,version 1.2017,NCCN clinical practice guidelines in oncology[J].JNatl Compr Canc Netw,2017,15(3):370-398.
[18]刘传玲,张晓东.左右半结肠癌的差异及临床治疗理念[J].中国肿瘤临床,2016,43(18):787-791.
[19]Jung MK,Shin US,Ki YJ,et al.Is the location of the tumor another prognostic factor for patients with colon cancer[J].Ann Coloproctol,2017,33(6):210-218.
[20]高显华,于冠宇,刘鹏,等.左半结肠癌与右半结肠癌临床病理特征及预后的比较[J].中华胃肠外科杂志,2017,20(6):647-653.
[21]翟志伟,顾晋.肿瘤大小对结肠癌患者预后的影响[J].中华胃肠外科杂志,2012,15(5):495-498.
[22]陈文菊,吴书胜,罗会芹,等.Ⅰ~Ⅲ期根治术后左右半结肠癌预后差异分析[J].肿瘤,2017,37(9):981-988.
[23]Yang Y,Huang X,Sun J,et al.Prognostic value of perineural invasion in colorectal cancer:a meta-analysis[J].J Gastrointest Surg,2015,19(6):1113-1122.
[24]Ceelen W,Van Nieuwenhove Y,Pattyn P.Prognostic value of the lymph node ratio in stageⅢcolorectal cancer:a systematic review[J].Ann Surg Oncol,2010,17(11):2847-2855.
[25]Walker R,Wood T,Le Souder E,et al.Comparison of two novel staging systems with the TNM system in predicting stageⅢcolon cancer survival[J].J Surg Oncol,2018,117(5):1049-1057.
[26]李道娟,李倩,贺宇彤.结直肠癌流行病学趋势[J].肿瘤防治研究,2015,42(3):305-310.
[27]崔建明,李繁宏,程腾.结直肠癌患者脉管癌栓与预后的相关性分析[J].重庆医学,2017,46(20):2791-2792,2796.
[28]Das V,Kalita J,Pal M.Predictive and prognostic biomarkers in colorectal cancer:a systematic review of recent advances and challenges[J].Biomed Pharmacother,2017,87:8-19.
[29]李拥军,邓飞,张雪琴,等.XELOX和OLF化疗方案治疗老年晚期结肠癌的疗效及安全性[J].中国老年学杂志,2015,35(1):237-238.
[30]Abraham A,Habermann EB,Rothenberger DA,et al.Adjuvant chemotherapy for stageⅢcolon cancer in the oldest old:results beyond clinical guidelines[J].Cancer,2013,119(2):395-403.
